1. Butenafine 1% versus Terbinafine 1% in Cream for the Treatment of Tinea Pedis

   • Tanweer A. Syed
   • Suhail M. Hadi
   • Seyed Ali Ahmad

   Clinical Use 17 September 2012 Pages: 393 - 397

   

2. Collagenase Ointment Application at 24-versus 48-hour Intervals in the Treatment of Pressure Ulcers

   • A. Burgos
   • J. Giménez
   • C. Rivera

   Clinical Use 17 September 2012 Pages: 399 - 407

   

3. Antithrombotic Therapy in Non-ST-Segment Elevation Acute Coronary Syndromes

   • Rio de la Plata Expert Panel

   Clinical Use 17 September 2012 Pages: 409 - 420

   

4. Cefuroxime Axetil in Short-Course Therapy of Tonsillopharyngitis

   • Willis Manford Gooch
   • Pierre Gehanno
   • Anne M. Harris

   Clinical Use 17 September 2012 Pages: 421 - 430

   

5. Clinical Effectiveness of Irbesartan and Irbersartan plus Hydrochlorothiazide in Women with Mild to Moderate Essential Hypertension

   • Eduardo Meaney-Mendiolea
   • Enrique Morales-Villegas
   • Carlos A. González-García

   Clinical Use 17 September 2012 Pages: 431 - 439

   

6. Captopril Does Not Influence the Components of Free Radical Activity Following Acute Myocardial Infarction

   • Krystyna Herbaczynska-Cedro
   • Beata Klosiewicz-Wasek

   Clinical Pharmacodynamics 17 September 2012 Pages: 441 - 445

   

7. Influence of Drugs on Sleep Apnoea in Stroke Patients

   • Olov Sandberg
   • Karl A. Franklin
   • Yngve Gustafson

   Clinical Pharmacovigilance 17 September 2012 Pages: 447 - 455

   

8. Antihyperlipidaemic Drugs

   • A. Gaddi
   • P. Berto
   • F. Cantagalli

   Pharmacoepidemiology 17 September 2012 Pages: 457 - 464

   

9. Nateglinide, a New Mealtime Glucose Regulator

   • Honghui Zhou
   • Yulia H. Walter
   • James F. McLeod

   Pharmacokinetics 17 September 2012 Pages: 465 - 471

   

10. Pharmacokinetics of Reboxetine in Volunteers with Hepatic Impairment

    • A. Tran
    • J. P. Laneury
    • P. Rampal

    Pharmacokinetics 17 September 2012 Pages: 473 - 477